Skip to main content

Dietary supplements won’t solve fertility problems, federal regulators say

Couples having trouble conceiving a child may try many treatments, but federal regulators said that one they shouldn’t try are dietary supplements produced by companies that claim their products can solve fertility problems.

The Federal Trade Commission and the Food and Drug Administration are teaming up to try to force companies to stop making claims that aren’t science-based and that can put your health at serious risk.

The regulators said five companies in particular falsely imply that their products meet FDA guidelines and that they treat, lessen, or prevent infertility and other reproductive health conditions.

“Women and families who face fertility issues deserve the best that science has to offer,” said Daniel Kaufman, acting director of the FTC’s Bureau of Consumer Protection, in a statement.

“The FTC is proud to work with the FDA to ensure that when companies make claims about fertility treatments and cures, those claims are backed by solid scientific evidence.”

The agencies have sent warning letters ordering the companies to remove unproven claims from their marketing materials.

The warnings were sent to LeRoche Benicoeur/ConceiveEasy, EU Natural Inc., Fertility Nutraceuticals LLC, SAL NATURE LLC/FertilHerb, and NS Products, Inc.

“Dietary supplements that claim to cure, treat, mitigate, or prevent infertility and other reproductive health conditions are unapproved new drugs that can potentially harm consumers who use these products instead of seeking effective treatments, such as FDA-approved drugs or assisted reproductive technology,” said Judy McMeekin, FDA’s Associate Commissioner for Regulatory Affairs in a statement.

“Protecting the health and safety of Americans is the FDA’s highest priority, and we will remain vigilant in communicating about products and companies that place U.S. consumers at risk.”

The companies could be fined almost $45,000 per violation and ordered to pay refunds to consumers who bought the allegedly deceptively marketed products.

The letters required the companies to notify the FTC by email within 15 working days of receipt of the specific actions they have taken to address the concerns.

Massachusetts court hears arguments in lawsuit alleging Meta designed apps to be addictive to kids

BOSTON (AP) — Massachusetts' highest court heard oral arguments Friday in the state's lawsuit arguing that Meta designed features on Facebook and Instagram to make them addictive to young users. The lawsuit, filed in 2023 by Attorney General Andrea Campbell, alleges that Meta did this to make a profit and that its actions affected hundreds of thousands of teenagers in Massachusetts who use the social media platforms. “We are making claims based only on the tools that Meta has developed because its own research shows they encourage addiction to the platform in a variety of ways,” said State Solicitor David Kravitz, adding that the state's claim has nothing to do the company's algorithms or failure to moderate content. Meta said Friday that it strongly disagrees with the allegations and is “confident the evidence will show our longstanding commitment to supporting young people.” Its attorney, Mark Mosier, argued in court that the lawsuit “would impose liabilities for performing traditional publishing functions” and that its actions are protected by the First Amendment.
Read Next Story